Literature DB >> 25025350

Ivacaftor: from bench to bedside... and back again.

Kevin Molloy1, Noel G McElvaney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25025350     DOI： 10.1164/rccm.201406-1122ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  5 in total

1.  Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014.

Authors:  Alvar Agustí; Josep Maria Antó; Charles Auffray; Ferran Barbé; Esther Barreiro; Jordi Dorca; Joan Escarrabill; Rosa Faner; Laura I Furlong; Judith Garcia-Aymerich; Joaquim Gea; Bertil Lindmark; Eduard Monsó; Vicente Plaza; Milo A Puhan; Josep Roca; Juan Ruiz-Manzano; Laura Sampietro-Colom; Ferran Sanz; Luis Serrano; James Sharpe; Oriol Sibila; Edwin K Silverman; Peter J Sterk; Jacob I Sznajder
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

2.  Nasospheroids permit measurements of CFTR-dependent fluid transport.

Authors:  Jennifer S Guimbellot; Justin M Leach; Imron G Chaudhry; Nancy L Quinney; Susan E Boyles; Michael Chua; Inmaculada Aban; Ilona Jaspers; Martina Gentzsch
Journal:  JCI Insight       Date:  2017-11-16

3.  CFTR function and clinical response to modulators parallel nasal epithelial organoid swelling.

Authors:  Justin D Anderson; Zhongyu Liu; L Victoria Odom; Latona Kersh; Jennifer S Guimbellot
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-05-19       Impact factor: 6.011

4.  Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation.

Authors:  Gemma L Zeybel; Jeffrey P Pearson; Amaran Krishnan; Stephen J Bourke; Simon Doe; Alan Anderson; Shoaib Faruqi; Alyn H Morice; Rhys Jones; Melissa McDonnell; Mujdat Zeybel; Peter W Dettmar; Malcolm Brodlie; Chris Ward
Journal:  J Cyst Fibros       Date:  2016-07-27       Impact factor: 5.482

Review 5.  Targeted therapies to improve CFTR function in cystic fibrosis.

Authors:  Malcolm Brodlie; Iram J Haq; Katie Roberts; J Stuart Elborn
Journal:  Genome Med       Date:  2015-09-24       Impact factor: 11.117
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.